AGPS and Alzheimer disease: As revealed in previous studies, amyloid deposition as measured by AV45–PET has an impact on cognition in early stages, while ADAS–Cog13 is not sensitive enough for measuring changes in early cognitive stage of MCI or AD [36, 37].